Is a complete CSE/DRUG research report available?

No complete published report is available for cse/DRUG (CSE/DRUG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/DRUG (CSE/DRUG)

Canadian Securities Exchange: CSE/DRUG · CAD

CA$77.8

+1.88 (+2.5%)· Recorded snapshot

Market cap	767M
Net income (ttm)	-24.5M
EPS (ttm)	-CA$2.86
Shares out	9.9M
Volume	300
Beta	0.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -24.5M
EPS (ttm): -CA$2.86
Market cap: 767M

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-23
Employees	26
Employees change	25
Employees growth	2,500%
Enterprise value	CAD 459.3M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA10919W4056
Last earnings date	2026-02-10
Last refreshed	2026-10-28
Last stock split date	2023-07-14
Last stock split type	Reverse
Market cap	CAD 767M
Next earnings date	2026-12-23
Price	CAD 77.76
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	cse/DRUG
Website	https://brightmindsbio.com

Metric

Value

Amount currency

CAD

Country

Canada

Country code

Earnings date

2026-12-23

Employees

Employees change

Employees growth

2,500%

Enterprise value

CAD 459.3M

Exchange

Canadian Securities Exchange

Financial currency

CAD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

September

Founded

2017

Industry

Biotechnology

Is primary listing

Yes

ISIN number

CA10919W4056

Last earnings date

2026-02-10

Last refreshed

2026-10-28

Last stock split date

2023-07-14

Last stock split type

Reverse

Market cap

CAD 767M

Next earnings date

2026-12-23

Price

CAD 77.76

Price currency

CAD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

cse/DRUG

Website

https://brightmindsbio.com

Metric	Value
Earnings yield	-3.68%
P/B ratio	2.43x
Price / tangible book value	2.43x

Metric

Value

Earnings yield

-3.68%

P/B ratio

2.43x

Price / tangible book value

2.43x

Metric	Value
Profit per employee	CAD -942,646
ROA	-13.5%
ROA (5Y)	-40.07%
ROCE	-12.73%
ROE	-13.63%
ROE (5Y)	-69.2%
ROIC	-13.61%

Metric

Value

Profit per employee

CAD -942,646

ROA

-13.5%

ROA (5Y)

-40.07%

ROCE

-12.73%

ROE

-13.63%

ROE (5Y)

-69.2%

ROIC

-13.61%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	CAD 76,057
EBIT	CAD -39.2M
EPS	CAD -2.86
Financing cash flow	CAD 275.3M
Net borrowing	CAD -104,771
Net cash flow	CAD 256.4M
Net income	CAD -24.5M
Operating cash flow minus SBC	CAD -29.8M
Operating income	CAD -39.2M
Stock-based compensation	CAD 5.1M

Metric

Value

Depreciation and amortization

CAD 76,057

EBIT

CAD -39.2M

EPS

CAD -2.86

Financing cash flow

CAD 275.3M

Net borrowing

CAD -104,771

Net cash flow

CAD 256.4M

Net income

CAD -24.5M

Operating cash flow minus SBC

CAD -29.8M

Operating income

CAD -39.2M

Stock-based compensation

CAD 5.1M

Metric	Value
Book value per share	CAD 31.20
Debt / equity	0
Interest coverage	-753.5
Long-term assets	CAD 52,920
Long-term liabilities	CAD 0
Net cash (debt)	CAD 307.8M
Net cash / market cap	41.12%
Net cash growth	500.55%
Net debt / equity	-1
Piotroski F-Score	1
Property, plant and equipment	CAD 52,920
Shareholders' equity	CAD 307.8M
Tangible book value	CAD 307.8M
Tangible book value per share	CAD 31.20
Total assets	CAD 310.3M
Total cash	CAD 307.8M
Total debt	CAD 65,589
Total liabilities	CAD 2.5M
WACC	5.54%

Metric

Value

Book value per share

CAD 31.20

Debt / equity

Interest coverage

-753.5

Long-term assets

CAD 52,920

Long-term liabilities

CAD 0

Net cash (debt)

CAD 307.8M

Net cash / market cap

41.12%

Net cash growth

500.55%

Net debt / equity

-1

Piotroski F-Score

Property, plant and equipment

CAD 52,920

Shareholders' equity

CAD 307.8M

Tangible book value

CAD 307.8M

Tangible book value per share

CAD 31.20

Total assets

CAD 310.3M

Total cash

CAD 307.8M

Total debt

CAD 65,589

Total liabilities

CAD 2.5M

WACC

5.54%

Metric	Value
Current assets	CAD 310.3M
Current liabilities	CAD 2.5M
Current ratio	121.97
Net working capital	CAD -23,186
Quick ratio	121.44
Working capital	CAD 307.7M

Metric

Value

Current assets

CAD 310.3M

Current liabilities

CAD 2.5M

Current ratio

121.97

Net working capital

CAD -23,186

Quick ratio

121.44

Working capital

CAD 307.7M

Metric	Value
Buyback yield / dilution	-38.94%
Shareholder yield	-38.94%

Metric

Value

Buyback yield / dilution

-38.94%

Shareholder yield

-38.94%

Metric	Value
150-day SMA	CAD 99.54
1D price change	2.48%
1M price change	4.64%
1M total return	4.64%
1W price change	-2.4%
1W total return	-2.4%
1Y price change	-5.14%
1Y return CAGR	-5.14%
1Y total return	-5.14%
20-day SMA	CAD 73.85
200-day SMA	CAD 102.89
3M price change	-23.88%
3M total return	-23.88%
3Y price change	3,767.5%
3Y return CAGR	238.08%
3Y total return	3,767.5%
50-day SMA	CAD 85.69
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 170.00
52-week high date	2026-01-06
52-week low	CAD 68.02
52-week low date	2026-10-06
5Y price change	77.82%
5Y return CAGR	12.2%
5Y total return	77.82%
6M price change	-36.36%
6M total return	-36.36%
All-time high	CAD 170.00
All-time high date	2026-01-06
All-time low	CAD 1.29
All-time low date	2024-04-30
Average true range (ATR)	CAD 3.20
Average volume	573.7
Beta (1Y)	2.3
Beta (2Y)	1.67
Beta (5Y)	0.23
Change from 52-week high	-54.26%
Change from 52-week low	14.32%
Change from all-time high	-54.5%
Change from all-time low	5,896.12%
Change from open	1.83%
Day's gap	0.63%
Dollar volume	CAD 23,328
High price	CAD 77.76
Low price	CAD 76.36
Monthly RSI	51.39
Open price	CAD 76.36
Position in 52-week range	100%
Previous close	CAD 75.88
Price vs 150-day SMA	-22.3%
Price vs 20-day SMA	4.75%
Price vs 200-day SMA	-24.82%
Price vs 50-day SMA	-9.73%
Relative volume	0.52
RSI	49.47
Sharpe ratio	0.2
Sharpe ratio (3Y)	0.64
Sortino ratio	0.4
Sortino ratio (3Y)	11.97
Volume	300
Weekly RSI	41.11
YTD price change	-29.96%
YTD total return	-29.96%

Metric

Value

150-day SMA

CAD 99.54

1D price change

2.48%

1M price change

4.64%

1M total return

4.64%

1W price change

-2.4%

1W total return

-2.4%

1Y price change

-5.14%

1Y return CAGR

-5.14%

1Y total return

-5.14%

20-day SMA

CAD 73.85

200-day SMA

CAD 102.89

3M price change

-23.88%

3M total return

-23.88%

3Y price change

3,767.5%

3Y return CAGR

238.08%

3Y total return

3,767.5%

50-day SMA

CAD 85.69

50-day SMA vs 200-day SMA

50under200

52-week high

CAD 170.00

52-week high date

2026-01-06

52-week low

CAD 68.02

52-week low date

2026-10-06

5Y price change

77.82%

5Y return CAGR

12.2%

5Y total return

77.82%

6M price change

-36.36%

6M total return

-36.36%

All-time high

CAD 170.00

All-time high date

2026-01-06

All-time low

CAD 1.29

All-time low date

2024-04-30

Average true range (ATR)

CAD 3.20

Average volume

573.7

Beta (1Y)

2.3

Beta (2Y)

1.67

Beta (5Y)

0.23

Change from 52-week high

-54.26%

Change from 52-week low

14.32%

Change from all-time high

-54.5%

Change from all-time low

5,896.12%

Change from open

1.83%

Day's gap

0.63%

Dollar volume

CAD 23,328

High price

CAD 77.76

Low price

CAD 76.36

Monthly RSI

51.39

Open price

CAD 76.36

Position in 52-week range

100%

Previous close

CAD 75.88

Price vs 150-day SMA

-22.3%

Price vs 20-day SMA

4.75%

Price vs 200-day SMA

-24.82%

Price vs 50-day SMA

-9.73%

Relative volume

0.52

RSI

49.47

Sharpe ratio

0.2

Sharpe ratio (3Y)

0.64

Sortino ratio

0.4

Sortino ratio (3Y)

11.97

Volume

300

Weekly RSI

41.11

YTD price change

-29.96%

YTD total return

-29.96%

Metric	Value
Float	6.7M
Shares change (QoQ)	2.51%
Shares change (YoY)	38.94%
Shares held by insiders	11.41%
Shares held by institutions	74.76%
Shares outstanding	9.9M

Metric

Value

Float

6.7M

Shares change (QoQ)

2.51%

Shares change (YoY)

38.94%

Shares held by insiders

11.41%

Shares held by institutions

74.76%

Shares outstanding

9.9M

CSE/DRUG (CSE/DRUG)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/DRUG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/DRUG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/DRUG

Frequently asked questions